QF:NMED Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The firm develops a non-hallucinogenic version of the psychedelic ibogaine. The company was founded by Stephen L. Hurst, Stanley D. Glick, and Jamon Alexander Rahn in 2019 and is headquarter in Toronto, Canada.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol MNMD.

This company has cross-listed shares that trade in the U.S. as the symbol MNMD.

0.00
As of 01/29/2023

---

Security Information

---

Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  
Index country:  Canada
Country of incorporation:  
IPO date:  01/01/1900
Stock exchange:    NEO Exchange
Exchange country:   Canada
Market cap:   0 CAD
Current dividend yield:   0.00%
Sedol: